Characterization of Dyslipidemia in Adolescent Obesity

Completed

• Conditions: Obesity

• Registration Number: NCT01988454
• Lead Sponsor: Health Diagnostic Laboratory, Inc.

Brief Summary

The primary objective of this pilot study is to characterize the profile of lipoprotein, inflammatory, and metabolic markers of cardiovascular disease in obese adolescents as compared to normal-weight age-matched controls.

Detailed Description

Not available

Study Timeline

• Study Start: 2011-09
• Study First Submitted: 2013-11-07
• Study First Submitted QC: 2013-11-13
• Study First Posted: 2013-11-20
• Primary Completion: 2014-06
• Study Completion: 2014-06
• Status Verified: 2015-02
• Last Update Submitted: 2015-02-12
• Last Update Posted: 2015-02-13

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• Age 13-19
• BMI ≥25 (obese) or <25 (normal weight)

Exclusion Criteria

• Prior diagnosis of any eating disorder (e.g. anorexia or bulimia)
• Prior diagnosis of any congenital lipid disorder (e.g. familial hypercholesterolemia)
• Current use (or within past 6 months) of any lipid altering medications

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Comparison of biomarker profiles	Baseline	To characterize and compare lipoprotein, inflammation and metabolic markers in obese and normal weight adolescents.

Trial Locations

Locations (1)

The Center for Nutrition and Preventive Medicine; 🇺🇸 Charlotte, North Carolina, United States